PharmTech

Integrating AI and Machine Learning in Drug Discovery and Development

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...
TMCnet

Converge Bio raises $25M to bring generative AI drug discovery to every biotech and pharmaceutical company

Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding ...

Converge Bio raises $25M, backed by Bessemer and execs from Meta, OpenAI, Wiz

AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional ...
The Indianapolis Star

Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery

Proprietary safety intelligence creates dual value: faster therapeutic development and biodefense. LOS ANGELES, CALIFORNIA / ACCESS Newswire / September 9, 2025 / Lunai Bioworks Inc. (NASDAQ:RENB), an ...
Analytics Insight

Variational AI

Variational AI, a Vancouver-based Healthcare Tech Company, advances Generative AI Drug Discovery by designing novel small ...
News Medical

Advancing drug discovery with AI, generative chemistry, and 3D molecular design

Discover how Optibrium is transforming early-stage drug discovery through AI-powered software, generative chemistry, and 3D modelling. In this interview, Matt Segall, CEO at Optibrium, shares insights ...
HTR Media

Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery

This post was originally published on this site. Proprietary safety intelligence creates dual value: faster therapeutic development and biodefense. LOS ANGELES, CALIFORNIA / ACCESS Newswire / ...